Vivodyne
2 known investors
Vivodyne is a bio-AI company that develops lab-grown human tissues and robotic systems to generate causal biological data for therapeutic development. The platform produces high-resolution phenomic, transcriptomic, and proteomic data from human tissue models to enable drug discovery and development.
Investors · 2
In the news
- Vivodyne Raises $40 Million to Advance Human Tissue Testing Platform - Penn Center for Innovationpci.upenn.edu · 2025
- Vivodyne Raises $40M to Transform Drug Development with AI-Powered Human Tissue Testinghlth.com · 2025
- Vivodyne raises $40 million for work on animal testing alternativesstatnews.com · 2025
- Vivodyne raises $40 million in funding round led by Khosla Venturesaxios.com · 2025
- Vivodyne Raises $40M in Series A Fundingfinsmes.com · 2025
- Vivodyne - 2026 Funding Rounds & List of Investors - Tracxntracxn.com · 2021